New RPS ‘reclassifications hub’ offers guidance on supply of P medicines

An online hub giving guidance to pharmacists who sell or supply medicines that have been reclassified from prescription-only medicine (POM) to pharmacy (P) status has been launched by the Royal Pharmaceutical Society (RPS). 

The reclassifications hub offers guidance to RPS members selling products which have been reclassified from POM to P, meaning that they should only be sold in a registered pharmacy under the supervision of a pharmacist.

The hub, accessible via the RPS website, includes drug indications, side effects and interactions, as well as advice on when a customer seeking to purchase a P medicine should be referred to their GP.

Currently, the hub features eight medicines, including weight loss drug orlistat, chloramphenicol eye drops and the migraine relief medication, sumatriptan.